Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
We dont recommend taking the first dose of an increased strength while away travelling, as this is a high-risk point for side effects, and we recommend starting a new dose strength once home or remaining on the same dose for an additional month if travelling for a significant period
Tirzepatide is a prescription glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) 30 kg/m (obesity), or 27 kg/m (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, or dyslipidemia)
Finally, one can foresee a future where combination therapy becomes common: for example, a patient with diabetes and obesity might be on both a GLP-1 RA and an SGLT2 inhibitor (for complementary weight loss and cardio-renal protection, which is already done)
A 2A receptors and dopamine D 2 receptors interact with each other, and A 2A receptor activation inhibits the function of the D 2 receptor under normal conditions
Professionally packaged for laboratory use
US$ 27.76
US$ 21.77
US$ 25.57
US$ 29.93
US$ 28.78
